A Fed governor speaks of accommodation, and AMC Entertainment's bond maneuvers serve as a warning to those who swim in the high-yield pool.
Fashion retailer Fossil Group climbed after posting results while downtrodden restaurant operator Luby's surged on the possible sale of its assets.
No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.
What new management means for Mylan shareholders moving forward.
Pfizer will combine its off-patent drug business with Mylan in the as-yet-to-be-named new company.
Is a turnaround even possible anymore?
Will BBBY be the next retailer to bite the dust?
There are no signs of accumulation of the beleaguered bank's shares and a sustainable base pattern is lacking.
Deutsche is looking to drop the "bad bank" moniker with big moves on Monday.
The $17 billion acquisition of Caesars by Eldorado is welcomed by activist investor Carl Icahn, who had been pushing Caesars board for a deal.